首页 > 最新文献

Canadian Journal of Kidney Health and Disease最新文献

英文 中文
Technical and Institutional Factors Affecting Specimen Adequacy and Complications in Ultrasound-guided Kidney Biopsy: A Retrospective Cohort Study. 超声引导肾活检中影响标本充足性和并发症的技术和制度因素:一项回顾性队列研究。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-05-06 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251336551
Sydney Murray, Chance Dumaine, Chris Wall, Tamalina Banerjee, James Barton, Michael Moser
<p><strong>Background: </strong>Percutaneous ultrasound-guided kidney biopsy is a critical diagnostic tool with a higher rate of complications than most other biopsies. Our prior research identified technical factors that might improve outcomes.</p><p><strong>Objective: </strong>The objective was to measure the impact of these technical and institutional interventions on specimen adequacy and complication rates in kidney biopsies.</p><p><strong>Design: </strong>This is a retrospective cohort study comparing outcomes before and after intervention implementation.</p><p><strong>Setting: </strong>Two hospitals within a single health region in Saskatchewan serving a population of approximately 1 million.</p><p><strong>Patients: </strong>All adult percutaneous ultrasound-guided kidney biopsies performed on adult patients between 2012 to 2016 (n = 242, pre-implementation) and 2017 to 2021 (n = 338, post-implementation). Both native and transplant biopsies were included, while patients under 18, open biopsies, and biopsies of kidney masses were excluded.</p><p><strong>Measurements: </strong>Primary outcomes included specimen adequacy and biopsy complications (hematoma, hemoglobin drop, infection, and arteriovenous fistula formation).</p><p><strong>Methods: </strong>Technical recommendations included introducing the biopsy needle at a 60° angle, targeting a pole, and avoiding the vascular medulla. Institutional recommendations included microscopic screening for all biopsies, limiting the number of radiologists performing procedures, using a checklist, and restricting computed tomography (CT)-guided biopsies to exceptional cases. Multivariate regression analysis assessed biopsy outcomes before and after the recommendations, controlling for known confounders while at the same time refining factors associated with fewer complications and greater diagnostic yield.</p><p><strong>Results: </strong>The rate of non-diagnostic specimens decreased from 10.3% to 4.4% (<i>P</i> = .005), and complications decreased from 35.5% to 14.2% (<i>P</i> < .0001). Two or three passes yielded excellent diagnostic success, while 4 passes increased the risk of a complication. Multivariate analysis, after accounting for the collinearity of certain technical factors revealed that medulla avoidance and biopsies done after the implementation of the 2016 recommendations significantly reduced the risk of complications (odds ratio [OR] = 0.37, <i>P</i> < .001) and non-diagnostic biopsies (OR = 0.31, <i>P</i> = .002).</p><p><strong>Limitations: </strong>Retrospective design and novelty bias may be a cause of bias in this study. Because the institutional recommendations were followed for all biopsies, it was not possible to distinguish which recommendation was most associated with the improvements. Because our study was done in a single health region, it is not clear if they are generalizable to other programs.</p><p><strong>Conclusions: </strong>The technical and institutional interventio
背景:经皮超声引导下肾活检是一种重要的诊断工具,其并发症发生率高于大多数其他活检。我们之前的研究确定了可能改善结果的技术因素。目的:目的是衡量这些技术和制度干预对肾活检标本充足性和并发症发生率的影响。设计:这是一项回顾性队列研究,比较干预实施前后的结果。环境:萨斯喀彻温省单一卫生区域内的两家医院为大约100万人口提供服务。患者:2012年至2016年(242例,实施前)和2017年至2021年(338例,实施后)对成年患者进行的所有成人经皮超声引导肾活检。原生活检和移植活检均包括在内,而18岁以下患者、开放活检和肾肿块活检除外。测量:主要结果包括标本充分性和活检并发症(血肿、血红蛋白下降、感染和动静脉瘘形成)。方法:技术建议包括穿刺针以60°角穿刺,穿刺针杆,避开血管髓质。机构建议包括对所有活组织检查进行显微筛查,限制执行手术的放射科医生的数量,使用检查清单,并将计算机断层扫描(CT)引导的活组织检查限制在特殊情况下。多变量回归分析评估了推荐前后的活检结果,控制了已知的混杂因素,同时细化了与并发症减少和诊断率提高相关的因素。结果:未诊断标本率由10.3%降至4.4% (P = 0.005),并发症由35.5%降至14.2% (P < 0.0001)。两次或三次检查获得了极好的诊断成功,而四次检查增加了并发症的风险。在考虑了某些技术因素的共线性后,多因素分析显示,在实施2016年建议后,髓质回避和活检显著降低了并发症的风险(优势比[OR] = 0.37, P < 0.001)和非诊断性活检(OR = 0.31, P = 0.002)。局限性:回顾性设计和新颖性偏倚可能是本研究偏倚的一个原因。由于所有活组织检查都遵循了机构建议,因此不可能区分哪种建议与改善最相关。因为我们的研究是在一个单一的卫生地区进行的,所以不清楚它们是否可以推广到其他项目。结论:超声引导肾活检的技术和制度干预显著提高了标本的充分性,降低了并发症的发生率。我们增加了这些建议,因为我们已经改进了活检针倾斜的要求,以方便使用,并建议尽可能将次数限制在2或3次。
{"title":"Technical and Institutional Factors Affecting Specimen Adequacy and Complications in Ultrasound-guided Kidney Biopsy: A Retrospective Cohort Study.","authors":"Sydney Murray, Chance Dumaine, Chris Wall, Tamalina Banerjee, James Barton, Michael Moser","doi":"10.1177/20543581251336551","DOIUrl":"https://doi.org/10.1177/20543581251336551","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Percutaneous ultrasound-guided kidney biopsy is a critical diagnostic tool with a higher rate of complications than most other biopsies. Our prior research identified technical factors that might improve outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The objective was to measure the impact of these technical and institutional interventions on specimen adequacy and complication rates in kidney biopsies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;This is a retrospective cohort study comparing outcomes before and after intervention implementation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;Two hospitals within a single health region in Saskatchewan serving a population of approximately 1 million.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;All adult percutaneous ultrasound-guided kidney biopsies performed on adult patients between 2012 to 2016 (n = 242, pre-implementation) and 2017 to 2021 (n = 338, post-implementation). Both native and transplant biopsies were included, while patients under 18, open biopsies, and biopsies of kidney masses were excluded.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Measurements: &lt;/strong&gt;Primary outcomes included specimen adequacy and biopsy complications (hematoma, hemoglobin drop, infection, and arteriovenous fistula formation).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Technical recommendations included introducing the biopsy needle at a 60° angle, targeting a pole, and avoiding the vascular medulla. Institutional recommendations included microscopic screening for all biopsies, limiting the number of radiologists performing procedures, using a checklist, and restricting computed tomography (CT)-guided biopsies to exceptional cases. Multivariate regression analysis assessed biopsy outcomes before and after the recommendations, controlling for known confounders while at the same time refining factors associated with fewer complications and greater diagnostic yield.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The rate of non-diagnostic specimens decreased from 10.3% to 4.4% (&lt;i&gt;P&lt;/i&gt; = .005), and complications decreased from 35.5% to 14.2% (&lt;i&gt;P&lt;/i&gt; &lt; .0001). Two or three passes yielded excellent diagnostic success, while 4 passes increased the risk of a complication. Multivariate analysis, after accounting for the collinearity of certain technical factors revealed that medulla avoidance and biopsies done after the implementation of the 2016 recommendations significantly reduced the risk of complications (odds ratio [OR] = 0.37, &lt;i&gt;P&lt;/i&gt; &lt; .001) and non-diagnostic biopsies (OR = 0.31, &lt;i&gt;P&lt;/i&gt; = .002).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Retrospective design and novelty bias may be a cause of bias in this study. Because the institutional recommendations were followed for all biopsies, it was not possible to distinguish which recommendation was most associated with the improvements. Because our study was done in a single health region, it is not clear if they are generalizable to other programs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The technical and institutional interventio","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251336551"},"PeriodicalIF":1.6,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12056320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nephrologist's Perceptions of Risk of Severe Chronic Kidney Disease and Outpatient Follow-up After Hospitalization With AKI: Multinational Randomized Survey Study. 肾科医生对严重慢性肾病风险的认知和急性肾损伤住院后的门诊随访:多国随机调查研究。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-04-30 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251336548
Dilaram Acharya, Tayler D Scory, Nusrat Shommu, Maoliosa Donald, Tyrone G Harrison, Jonathan S Murray, Simon Sawhney, Edward D Siew, Neesh Pannu, Matthew T James
<p><strong>Background: </strong>Patients hospitalized with acute kidney injury (AKI) have variable risks for chronic kidney disease (CKD); however, there is limited knowledge about how this risk influences outpatient follow-up with nephrologists.</p><p><strong>Objective: </strong>This survey study examined the likelihood that nephrologists would recommend outpatient follow-up of patients with varying risk profiles for CKD after hospitalization with AKI and the effect of reporting the predicted risk of severe CKD on their decision-making.</p><p><strong>Design: </strong>A randomized survey study examining the impact of providing predicted risks of severe CKD on nephrologists' follow-up recommendations for patients with AKI.</p><p><strong>Setting: </strong>The study included nephrologists from the United States, the United Kingdom, and Canada between September and December 2023.</p><p><strong>Patients: </strong>Participants reviewed clinical vignettes of patients with AKI and varying risks of severe CKD (G4 or G5), using an externally validated prediction model.</p><p><strong>Measurements: </strong>The primary outcome was the likelihood of recommending nephrologist specialist follow-up for each case, scored on a 7-point Likert scale (1 = "definitely not" and 7 = "definitely would").</p><p><strong>Methods: </strong>Participants were randomized to receive a version of the survey either with or without the predicted risk of severe CKD included for each vignette. Responses were compared across categories of predicted risk (<10%, 10%-49%, and ≥50%) using generalized estimating equations.</p><p><strong>Results: </strong>Of the 203 nephrologists who participated, 73 (36%) were from the United Kingdom, 71 (35%) from Canada, and 45 (22%) from the United States. Mean (95% confidence interval [CI]) Likert scores increased from 4.01 (3.68, 4.34) for patients with a <10% predicted risk to 6.06 (5.76, 6.37) for those with a ≥ 50% predicted risk of severe CKD. Nephrologists were significantly less likely to recommend outpatient nephrology follow-up for patients with a <10% predicted risk of severe CKD when the risk was reported (mean difference = -0.71 [95% CI = -1.19, -0.23]), and significantly more likely to recommend follow-up for patients with a ≥50% predicted risk when the risk of severe CKD was reported (mean difference = 0.49 [95% CI = 0.04, 0.93]).</p><p><strong>Limitations: </strong>This study focuses on nephrologists from high-income countries and relies on hypothetical scenarios rather than real-world practices. Survey respondents may not be representative of all nephrologists, although consistent findings across diverse subgroups strengthen findings.</p><p><strong>Conclusions: </strong>When the predicted risk of severe CKD is reported, nephrologists are less likely to recommend follow-up for lower risk patients with AKI and more likely to recommend follow-up for higher risk patients, leading to better alignment of recommendations for outpatient follow-
背景:急性肾损伤(AKI)住院患者发生慢性肾脏疾病(CKD)的风险不同;然而,关于这种风险如何影响肾脏科门诊随访的知识有限。目的:本调查研究探讨了肾病学家在AKI住院后推荐不同CKD风险概况的患者进行门诊随访的可能性,以及报告预测的严重CKD风险对他们决策的影响。设计:一项随机调查研究,研究提供严重CKD风险预测对肾科医生对AKI患者随访建议的影响。背景:该研究包括2023年9月至12月期间来自美国、英国和加拿大的肾病学家。患者:参与者使用外部验证的预测模型,回顾了AKI和不同风险的严重CKD (G4或G5)患者的临床资料。测量:主要结果是推荐每个病例的肾病专家随访的可能性,以7分的李克特量表评分(1 =“绝对不会”,7 =“肯定会”)。方法:参与者随机接受一个版本的调查,包括或不包括每个小插曲的严重CKD的预测风险。结果:参与研究的203名肾病学家中,73名(36%)来自英国,71名(35%)来自加拿大,45名(22%)来自美国。患者的平均(95%可信区间[CI])李克特评分从4.01(3.68,4.34)增加到a。局限性:本研究侧重于高收入国家的肾病学家,依赖于假设情景而非现实世界的实践。调查对象可能不能代表所有的肾病学家,尽管不同亚组的一致发现加强了研究结果。结论:当报告了严重CKD的预测风险时,肾病学家不太可能建议对低风险的AKI患者进行随访,而更可能建议对高风险患者进行随访,从而使门诊随访的建议与严重CKD患者的风险更好地一致。
{"title":"Nephrologist's Perceptions of Risk of Severe Chronic Kidney Disease and Outpatient Follow-up After Hospitalization With AKI: Multinational Randomized Survey Study.","authors":"Dilaram Acharya, Tayler D Scory, Nusrat Shommu, Maoliosa Donald, Tyrone G Harrison, Jonathan S Murray, Simon Sawhney, Edward D Siew, Neesh Pannu, Matthew T James","doi":"10.1177/20543581251336548","DOIUrl":"https://doi.org/10.1177/20543581251336548","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Patients hospitalized with acute kidney injury (AKI) have variable risks for chronic kidney disease (CKD); however, there is limited knowledge about how this risk influences outpatient follow-up with nephrologists.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This survey study examined the likelihood that nephrologists would recommend outpatient follow-up of patients with varying risk profiles for CKD after hospitalization with AKI and the effect of reporting the predicted risk of severe CKD on their decision-making.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;A randomized survey study examining the impact of providing predicted risks of severe CKD on nephrologists' follow-up recommendations for patients with AKI.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;The study included nephrologists from the United States, the United Kingdom, and Canada between September and December 2023.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;Participants reviewed clinical vignettes of patients with AKI and varying risks of severe CKD (G4 or G5), using an externally validated prediction model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Measurements: &lt;/strong&gt;The primary outcome was the likelihood of recommending nephrologist specialist follow-up for each case, scored on a 7-point Likert scale (1 = \"definitely not\" and 7 = \"definitely would\").&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Participants were randomized to receive a version of the survey either with or without the predicted risk of severe CKD included for each vignette. Responses were compared across categories of predicted risk (&lt;10%, 10%-49%, and ≥50%) using generalized estimating equations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the 203 nephrologists who participated, 73 (36%) were from the United Kingdom, 71 (35%) from Canada, and 45 (22%) from the United States. Mean (95% confidence interval [CI]) Likert scores increased from 4.01 (3.68, 4.34) for patients with a &lt;10% predicted risk to 6.06 (5.76, 6.37) for those with a ≥ 50% predicted risk of severe CKD. Nephrologists were significantly less likely to recommend outpatient nephrology follow-up for patients with a &lt;10% predicted risk of severe CKD when the risk was reported (mean difference = -0.71 [95% CI = -1.19, -0.23]), and significantly more likely to recommend follow-up for patients with a ≥50% predicted risk when the risk of severe CKD was reported (mean difference = 0.49 [95% CI = 0.04, 0.93]).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;This study focuses on nephrologists from high-income countries and relies on hypothetical scenarios rather than real-world practices. Survey respondents may not be representative of all nephrologists, although consistent findings across diverse subgroups strengthen findings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;When the predicted risk of severe CKD is reported, nephrologists are less likely to recommend follow-up for lower risk patients with AKI and more likely to recommend follow-up for higher risk patients, leading to better alignment of recommendations for outpatient follow-","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251336548"},"PeriodicalIF":1.6,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12046161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143972669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Life on the Line: Prioritizing Equity in Kidney Transplantation for Populations Marginalized by Race and Ethnicity. 生命在线:优先考虑种族和民族边缘化人群的肾脏移植公平。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-04-10 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251331076
Jagbir Gill, Reetinder Kaur
{"title":"Life on the Line: Prioritizing Equity in Kidney Transplantation for Populations Marginalized by Race and Ethnicity.","authors":"Jagbir Gill, Reetinder Kaur","doi":"10.1177/20543581251331076","DOIUrl":"https://doi.org/10.1177/20543581251331076","url":null,"abstract":"","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251331076"},"PeriodicalIF":1.6,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12032458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143978699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Problems We Can-SOLVE: How Can-SOLVE CKD Network Implementation and Knowledge Mobilization Projects Are Reshaping Kidney Care in Canada. 我们可以解决的问题:如何解决CKD网络实施和知识动员项目正在重塑加拿大的肾脏护理。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-04-09 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251333206
Cathy Woods, Maoliosa Donald, Selina Allu, Michelle Hampson, Cynthia MacDonald, Heather Harris, Malcolm King, James Scholey, Adeera Levin, Matthew T James
{"title":"The Problems We Can-SOLVE: How Can-SOLVE CKD Network Implementation and Knowledge Mobilization Projects Are Reshaping Kidney Care in Canada.","authors":"Cathy Woods, Maoliosa Donald, Selina Allu, Michelle Hampson, Cynthia MacDonald, Heather Harris, Malcolm King, James Scholey, Adeera Levin, Matthew T James","doi":"10.1177/20543581251333206","DOIUrl":"https://doi.org/10.1177/20543581251333206","url":null,"abstract":"","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251333206"},"PeriodicalIF":1.6,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12032431/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143963719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambulance Service Utilization by Kidney Transplant Recipients. 肾脏移植受者使用救护车服务的情况。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251324587
Kaveh Masoumi-Ravandi, Amanda Vinson, Aran Thanamayooran, Judah Goldstein, Thomas Skinner, Karthik Tennankore

Background: Compared with the general population, kidney transplant recipients (KTRs) frequently visit the emergency department (ED), but much less is known about the characteristics of ED presentations requiring ambulance transport and the impact on subsequent outcomes for KTRs.

Objectives: To identify predictors of ambulance transport to the ED (ambulance-ED) and outcomes (graft failure and mortality) for those who experienced an ambulance-ED event in a cohort of KTRs.

Design: Retrospective cohort study of incident, adult KTRs receiving a transplant from 2008 to 2020.

Setting: Nova Scotia, Canada.

Patients: Adult (≥18 years), Nova Scotian KTRs affiliated with the Atlantic Canada Multi-Organ Transplant Program.

Measurements: Ambulance-ED events were captured for all transplant recipients (following the day of discharge from their initial transplant admission) using electronic records (provided by Emergency Health Services, the sole provider of emergency medical services for Nova Scotia). Ambulance-ED was defined as ambulance transport to the ED following a 911 call; interfacility transfers were excluded. Predictors of ambulance-ED included recipient, donor, immunological, and perioperative characteristics (pertaining to the initial admission for kidney transplantation). Outcomes included graft failure and mortality.

Methods: Predictors of ambulance-ED were analyzed using a multivariable negative binomial regression model and reported using incidence rate ratios (IRRs) and 95% confidence intervals (CIs). The risk of death/graft failure for those with an ambulance-ED within 30 days of hospital discharge following transplantation was analyzed using an adjusted Cox survival analysis and reported using hazard ratios (HRs) and 95% CIs.

Results: A total of 418 patients received a transplant during the study period. A total of 179 (42.8%) experienced one or more ambulance-ED events. Female sex (IRR = 1.60; 95% CI = 1.12-2.29), kidney failure secondary to diabetes (IRR = 2.52; 95% CI = 1.19-5.31), and donor age ≥45 (IRR = 1.50; 95% CI = 1.04-2.15) were all associated with ambulance-ED. There was no significant increase in the risk of death/graft failure for those that experienced ambulance-ED within 30 days of hospital discharge following transplantation (HR = 1.31; 95% CI = 0.44-3.94).

Limitations: A limitation of this study was that ambulance-ED is not a perfect surrogate marker of acute care needs in a population. Important determinants of health such as living situation and socioeconomic status were not available in this data set.

Conclusions: This study highlights the burden of ambulance use for KTRs and provides insight into the need for more optimal follow-up in certain patient subgroups who are at particularly high risk.

背景:与一般人群相比,肾移植受者(KTRs)经常访问急诊科(ED),但对需要救护车运送的ED表现特征及其对肾移植受者后续结局的影响知之甚少。目的:确定在ktr队列中经历救护车-ED事件的患者的救护车转运到急诊室(救护车-ED)和结果(移植物衰竭和死亡率)的预测因素。设计:回顾性队列研究,对2008年至2020年接受移植的成年ktr患者进行研究。环境:加拿大新斯科舍省。患者:成人(≥18岁),隶属于加拿大大西洋多器官移植计划的新斯科舍省KTRs。测量:使用电子记录(由新斯科舍省唯一的紧急医疗服务提供者紧急卫生服务部门提供)记录了所有移植受者(从初次移植入院出院当天起)的救护车- ed事件。ambulance -ED被定义为在接到911报警电话后由救护车送往急诊室;设施间转移不包括在内。救护车- ed的预测因素包括受体、供体、免疫学和围手术期特征(与肾移植初次入院有关)。结果包括移植物衰竭和死亡。方法:采用多变量负二项回归模型对急诊急诊的预测因素进行分析,并采用发病率比(IRRs)和95%置信区间(ci)进行报告。采用校正Cox生存分析分析移植术后出院30天内急诊患者的死亡/移植失败风险,并采用危险比(hr)和95% ci进行报告。结果:在研究期间,共有418例患者接受了移植。共有179人(42.8%)经历过一次或多次急诊事件。女性(IRR = 1.60;95% CI = 1.12-2.29),继发于糖尿病的肾衰竭(IRR = 2.52;95% CI = 1.19-5.31),供体年龄≥45岁(IRR = 1.50;95% CI = 1.04-2.15)均与急诊相关。移植术后出院后30天内急诊患者死亡/移植失败的风险无显著增加(HR = 1.31;95% ci = 0.44-3.94)。局限性:本研究的一个局限性是救护车-急诊科并不是一个人群急性护理需求的完美替代标记。这组数据中没有生活状况和社会经济地位等重要的健康决定因素。结论:本研究强调了KTRs使用救护车的负担,并提供了对某些高危患者亚组进行更优化随访的需求。
{"title":"Ambulance Service Utilization by Kidney Transplant Recipients.","authors":"Kaveh Masoumi-Ravandi, Amanda Vinson, Aran Thanamayooran, Judah Goldstein, Thomas Skinner, Karthik Tennankore","doi":"10.1177/20543581251324587","DOIUrl":"10.1177/20543581251324587","url":null,"abstract":"<p><strong>Background: </strong>Compared with the general population, kidney transplant recipients (KTRs) frequently visit the emergency department (ED), but much less is known about the characteristics of ED presentations requiring ambulance transport and the impact on subsequent outcomes for KTRs.</p><p><strong>Objectives: </strong>To identify predictors of ambulance transport to the ED (ambulance-ED) and outcomes (graft failure and mortality) for those who experienced an ambulance-ED event in a cohort of KTRs.</p><p><strong>Design: </strong>Retrospective cohort study of incident, adult KTRs receiving a transplant from 2008 to 2020.</p><p><strong>Setting: </strong>Nova Scotia, Canada.</p><p><strong>Patients: </strong>Adult (≥18 years), Nova Scotian KTRs affiliated with the Atlantic Canada Multi-Organ Transplant Program.</p><p><strong>Measurements: </strong>Ambulance-ED events were captured for all transplant recipients (following the day of discharge from their initial transplant admission) using electronic records (provided by Emergency Health Services, the sole provider of emergency medical services for Nova Scotia). Ambulance-ED was defined as ambulance transport to the ED following a 911 call; interfacility transfers were excluded. Predictors of ambulance-ED included recipient, donor, immunological, and perioperative characteristics (pertaining to the initial admission for kidney transplantation). Outcomes included graft failure and mortality.</p><p><strong>Methods: </strong>Predictors of ambulance-ED were analyzed using a multivariable negative binomial regression model and reported using incidence rate ratios (IRRs) and 95% confidence intervals (CIs). The risk of death/graft failure for those with an ambulance-ED within 30 days of hospital discharge following transplantation was analyzed using an adjusted Cox survival analysis and reported using hazard ratios (HRs) and 95% CIs.</p><p><strong>Results: </strong>A total of 418 patients received a transplant during the study period. A total of 179 (42.8%) experienced one or more ambulance-ED events. Female sex (IRR = 1.60; 95% CI = 1.12-2.29), kidney failure secondary to diabetes (IRR = 2.52; 95% CI = 1.19-5.31), and donor age ≥45 (IRR = 1.50; 95% CI = 1.04-2.15) were all associated with ambulance-ED. There was no significant increase in the risk of death/graft failure for those that experienced ambulance-ED within 30 days of hospital discharge following transplantation (HR = 1.31; 95% CI = 0.44-3.94).</p><p><strong>Limitations: </strong>A limitation of this study was that ambulance-ED is not a perfect surrogate marker of acute care needs in a population. Important determinants of health such as living situation and socioeconomic status were not available in this data set.</p><p><strong>Conclusions: </strong>This study highlights the burden of ambulance use for KTRs and provides insight into the need for more optimal follow-up in certain patient subgroups who are at particularly high risk.</p","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251324587"},"PeriodicalIF":1.6,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient and Caregiver Perceptions on the Allocation Process and Waitlist, and Accepting a Less-Than-Ideal Kidney: A Canadian Survey. 患者和护理人员对分配过程和候补名单的看法,并接受一个不理想的肾脏:一项加拿大调查。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-04-03 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251324608
Marie-Chantal Fortin, Fabian Ballesteros Gallego, Héloise Cardinal, Manpreet Kaur, Rahul Mainra, Sylvain Patoine, Nicola Rosaasen, Holly Mansell

Background: Transplanting less-than-ideal (LTI) kidneys could help optimize organ utilization, but little is known about how patients and caregivers perceive the allocation process, waitlist, or LTI kidneys.

Objective: To explore the perspectives of patients and caregivers on the Canadian kidney transplant allocation process, waitlist, and LTI kidneys.

Design: Electronic survey.

Setting: Canada.

Patients: Transplant recipients, candidates, and caregivers.

Methods: A bilingual electronic national survey was administered from January to March 2024. The questionnaire contained sections on demographics, perceptions of organ allocation and acceptance, LTI kidneys, and educational preferences. Descriptive analysis was performed.

Results: Two hundred fifty-one responses were analyzed, including patients (63%, n = 159), and caregivers (37%, n = 92), from 11 provinces and territories. Three-quarters (74%, n = 186) understood how patients are placed on the waiting list, and 65% (n = 162) understood how donor kidneys are allocated, but 72% (n = 181) and 68% (n = 171) wanted more information about the waitlist and donor kidney allocation criteria, respectively. Approximately 20% felt that the waitlist and allocation processes were not transparent. Awareness about the option to refuse a deceased donor kidney offer was high (69%, n = 174), yet nearly half of respondents (46%, n = 115) expressed concern about being disadvantaged if an offer for a deceased donor kidney was refused. One-third of participants (33%, n = 83) were open to accepting an LTI kidney.

Limitations: Compared to the general population, more study participants were white, and the majority were educated and financially at ease. This limits the generalizability of the results.

Conclusion: Enhanced communication is required to improve transparency and information about the allocation system and waitlist in Canada.

背景:移植不理想(LTI)肾脏可以帮助优化器官利用,但很少了解患者和护理人员如何看待分配过程,等待名单或LTI肾脏。目的:探讨患者和护理人员对加拿大肾移植分配过程、等待名单和LTI肾脏的看法。设计:电子调查。设置:加拿大。患者:移植受者、候选者和护理者。方法:于2024年1 - 3月进行全国双语电子问卷调查。调查问卷包含人口统计、器官分配和接受的看法、LTI肾脏和教育偏好等部分。进行描述性分析。结果:分析了来自11个省和地区的251份回复,包括患者(63%,n = 159)和护理人员(37%,n = 92)。四分之三(74%,n = 186)的患者了解如何将患者放在等待名单上,65% (n = 162)的患者了解如何分配供肾,但72% (n = 181)和68% (n = 171)的患者分别希望了解更多关于等待名单和供肾分配标准的信息。大约20%的人认为候补名单和分配过程不透明。人们对拒绝已故捐赠者提供肾脏的选择的认识很高(69%,n = 174),但近一半的受访者(46%,n = 115)表示,如果拒绝提供已故捐赠者的肾脏,他们会处于不利地位。三分之一的参与者(33%,n = 83)对接受LTI肾脏持开放态度。局限性:与一般人群相比,更多的研究参与者是白人,大多数人受过教育,经济状况良好。这限制了结果的普遍性。结论:需要加强沟通,以提高加拿大分配制度和候补名单的透明度和信息。
{"title":"Patient and Caregiver Perceptions on the Allocation Process and Waitlist, and Accepting a Less-Than-Ideal Kidney: A Canadian Survey.","authors":"Marie-Chantal Fortin, Fabian Ballesteros Gallego, Héloise Cardinal, Manpreet Kaur, Rahul Mainra, Sylvain Patoine, Nicola Rosaasen, Holly Mansell","doi":"10.1177/20543581251324608","DOIUrl":"10.1177/20543581251324608","url":null,"abstract":"<p><strong>Background: </strong>Transplanting less-than-ideal (LTI) kidneys could help optimize organ utilization, but little is known about how patients and caregivers perceive the allocation process, waitlist, or LTI kidneys.</p><p><strong>Objective: </strong>To explore the perspectives of patients and caregivers on the Canadian kidney transplant allocation process, waitlist, and LTI kidneys.</p><p><strong>Design: </strong>Electronic survey.</p><p><strong>Setting: </strong>Canada.</p><p><strong>Patients: </strong>Transplant recipients, candidates, and caregivers.</p><p><strong>Methods: </strong>A bilingual electronic national survey was administered from January to March 2024. The questionnaire contained sections on demographics, perceptions of organ allocation and acceptance, LTI kidneys, and educational preferences. Descriptive analysis was performed.</p><p><strong>Results: </strong>Two hundred fifty-one responses were analyzed, including patients (63%, n = 159), and caregivers (37%, n = 92), from 11 provinces and territories. Three-quarters (74%, n = 186) understood how patients are placed on the waiting list, and 65% (n = 162) understood how donor kidneys are allocated, but 72% (n = 181) and 68% (n = 171) wanted more information about the waitlist and donor kidney allocation criteria, respectively. Approximately 20% felt that the waitlist and allocation processes were not transparent. Awareness about the option to refuse a deceased donor kidney offer was high (69%, n = 174), yet nearly half of respondents (46%, n = 115) expressed concern about being disadvantaged if an offer for a deceased donor kidney was refused. One-third of participants (33%, n = 83) were open to accepting an LTI kidney.</p><p><strong>Limitations: </strong>Compared to the general population, more study participants were white, and the majority were educated and financially at ease. This limits the generalizability of the results.</p><p><strong>Conclusion: </strong>Enhanced communication is required to improve transparency and information about the allocation system and waitlist in Canada.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251324608"},"PeriodicalIF":1.6,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Flow of Living Kidney Donor Candidates Through the Evaluation Process: A Single-Center Experience in Ontario, Canada. 通过评估过程的活体肾供者候选人的流动:加拿大安大略省的单中心经验。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-31 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251323964
Steven Habbous, Beth Montesi, Christy Masse, Corinne Weernink, Sisira Sarma, Mehmet A Begen, Ngan N Lam, Christine Dipchand, Seychelle Yohanna, Dervla M Connaughton, Lianne Barnieh, Amit X Garg

Introduction: Tracking the evaluation process of living kidney donor candidates facilitates benchmarking and can inform process redesign to improve experiences with the evaluation and enable more living donor kidney transplantation.

Methods: We reviewed the medical records for all living donor candidates who were actively undergoing evaluation at any time between January 1, 2013, and December 31, 2016, at the London Health Sciences Centre in London, Ontario, Canada. We abstracted information on demographic factors, the evaluation process, reasons for a delayed evaluation, reasons for an evaluation termination (eg, donation, decline, withdrawal, loss to follow-up), frequency and timing of evaluation testing, and recipient dialysis status.

Results: Over time, the number of living donor kidney transplants increased from 22 in 2013 to 32 in 2016 (18% and 34% of which were pre-emptive, respectively). The median number of candidates coming forward doubled from 167 in 2013 (2 candidates per recipient) to 348 in 2016 (4 candidates per recipient). Median time from first contact until donation decreased from 12.8 months in 2013 to 7.1 months in 2016 (a 45% reduction). The time from computed tomography (CT) angiography until donation (n = 74) was a median of 75 (interquartile range [IQR] = 36, 180) days, the longest single step in the evaluation. Common reasons for delay included waiting for the referral of their intended recipient for transplant evaluation (11% of candidates) and a need for the donor candidate to lose weight (8% of candidates). Donors completed the main evaluation tests on a median of 5 different dates. Thirty-six recipients started dialysis after their living donor candidates' evaluation had been underway for at least 3 months.

Conclusion: Tracking the steps and reasons for an inefficient living kidney donor evaluation process can be used for quality improvement, and efficiency improvements are expected to translate into improved outcomes and experiences.

导言:跟踪活体肾供者候选人的评估过程有助于制定基准,并可以为流程重新设计提供信息,以改善评估体验,并使更多的活体肾移植成为可能。方法:我们回顾了2013年1月1日至2016年12月31日期间在加拿大安大略省伦敦市伦敦健康科学中心积极接受评估的所有活体供体候选人的医疗记录。我们提取了人口统计因素、评估过程、延迟评估的原因、评估终止的原因(如:捐献、减少、退出、失去随访)、评估测试的频率和时间以及受者透析状态的信息。结果:随着时间的推移,活体肾移植数量从2013年的22例增加到2016年的32例(分别占18%和34%)。候选人的中位数从2013年的167人(每名候选人2人)增加到2016年的348人(每名候选人4人),翻了一番。从首次接触到捐献的中位数时间从2013年的12.8个月减少到2016年的7.1个月(减少了45%)。从CT血管造影到捐赠(n = 74)的时间中位数为75天(四分位数间距[IQR] = 36,180),是评估中最长的单步。延迟的常见原因包括等待指定受者进行移植评估(11%的候选人)和需要捐赠候选人减肥(8%的候选人)。捐助者在5个不同日期中位数完成了主要评估测试。36名受赠者在他们的活体供体候选人评估进行了至少3个月后开始透析。结论:对活肾供者评估流程效率低下的步骤和原因进行跟踪,可用于质量改进,效率改进有望转化为改善的结果和经验。
{"title":"The Flow of Living Kidney Donor Candidates Through the Evaluation Process: A Single-Center Experience in Ontario, Canada.","authors":"Steven Habbous, Beth Montesi, Christy Masse, Corinne Weernink, Sisira Sarma, Mehmet A Begen, Ngan N Lam, Christine Dipchand, Seychelle Yohanna, Dervla M Connaughton, Lianne Barnieh, Amit X Garg","doi":"10.1177/20543581251323964","DOIUrl":"10.1177/20543581251323964","url":null,"abstract":"<p><strong>Introduction: </strong>Tracking the evaluation process of living kidney donor candidates facilitates benchmarking and can inform process redesign to improve experiences with the evaluation and enable more living donor kidney transplantation.</p><p><strong>Methods: </strong>We reviewed the medical records for all living donor candidates who were actively undergoing evaluation at any time between January 1, 2013, and December 31, 2016, at the London Health Sciences Centre in London, Ontario, Canada. We abstracted information on demographic factors, the evaluation process, reasons for a delayed evaluation, reasons for an evaluation termination (eg, donation, decline, withdrawal, loss to follow-up), frequency and timing of evaluation testing, and recipient dialysis status.</p><p><strong>Results: </strong>Over time, the number of living donor kidney transplants increased from 22 in 2013 to 32 in 2016 (18% and 34% of which were pre-emptive, respectively). The median number of candidates coming forward doubled from 167 in 2013 (2 candidates per recipient) to 348 in 2016 (4 candidates per recipient). Median time from first contact until donation decreased from 12.8 months in 2013 to 7.1 months in 2016 (a 45% reduction). The time from computed tomography (CT) angiography until donation (n = 74) was a median of 75 (interquartile range [IQR] = 36, 180) days, the longest single step in the evaluation. Common reasons for delay included waiting for the referral of their intended recipient for transplant evaluation (11% of candidates) and a need for the donor candidate to lose weight (8% of candidates). Donors completed the main evaluation tests on a median of 5 different dates. Thirty-six recipients started dialysis after their living donor candidates' evaluation had been underway for at least 3 months.</p><p><strong>Conclusion: </strong>Tracking the steps and reasons for an inefficient living kidney donor evaluation process can be used for quality improvement, and efficiency improvements are expected to translate into improved outcomes and experiences.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251323964"},"PeriodicalIF":1.6,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11960183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Testicular Pain After Living Kidney Donation: Results From a Multicenter Cohort Study. 活体肾脏捐献后睾丸疼痛:来自多中心队列研究的结果。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-29 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251324610
Amit X Garg, Liane S Feldman, Jessica M Sontrop, Meaghan S Cuerden, Jennifer B Arnold, Neil Boudville, Martin Karpinski, Scott Klarenbach, Greg Knoll, Charmaine E Lok, Eric McArthur, Matthew Miller, Mauricio Monroy-Cuadros, Kyla L Naylor, G V Ramesh Prasad, Leroy Storsley, Christopher Nguan

Background: Some men who donate a kidney have reported testicular pain after donation; however, attribution to donation is not clear as no prior studies included a comparison group of nondonors.

Objective: To examine the proportion of male donors who reported testicular pain in the years after nephrectomy compared to male nondonors with similar baseline health characteristics.

Design participants and setting: We enrolled 1042 living kidney donors (351 male) before nephrectomy from 17 transplant centers (12 in Canada and 5 in Australia) from 2004 to 2014. A concurrent sample of 396 nondonors (126 male) was enrolled. Follow-up occurred until November 2021.

Measurements: Donors and nondonors completed the same schedule of measurements at baseline (before nephrectomy) and follow-up. During follow-up, participants completed a questionnaire asking whether they had experienced new pain in their eyes, hands, or testicles; those who experienced pain were asked to indicate on which side of the body the pain occurred (left or right). The pain questionnaire was completed by 290 of 351 male donors (83%) and 97 of 126 male nondonors (77%) a median of 3 years after baseline (interquartile range = 2-6).

Methods: Inverse probability of treatment weighting on a propensity score was used to balance donors and nondonors on baseline characteristics. After weighting, the nondonor sample increased to a pseudo sample of 295, and most baseline characteristics were similar between donors and nondonors.

Results: At baseline, donors (n = 290) were a mean age of 49 years; 83% were employed, and 80% were married; 246 (84.8%) underwent laparoscopic surgery and 44 (15.2%) open surgery; 253 (87.2%) had a left-sided nephrectomy and 37 (12.8%) a right-sided nephrectomy. In the weighted analysis, the risk of testicular pain was significantly greater among donors than nondonors: 51/290 (17.6%) vs 7/295 (2.3%); weighted risk ratio, 7.8 (95% confidence interval [CI] = 2.7 to 22.8). Donors and nondonors did not differ statistically in terms of self-reported eye pain or hand pain. Among donors, the occurrence of testicular pain was most often unilateral (92.2%) and on the same side as the nephrectomy (90.2%). Testicular pain occurred more often in donors who had laparoscopic vs open surgery: 48/246 (19.5%) vs 3/44 (6.8%) but was similar in those who had a left-sided vs right-sided nephrectomy: 44/253 (17.4%) vs 7/37 (18.9%).

Limitations: Participants recalled their symptoms several years after baseline, and we did not assess the timing, severity, or duration of pain or any treatments received for the pain.

Conclusion: Unilateral testicular pain on the same side of a nephrectomy is a potential complication of living kidney donation that warrants further investigation.

背景:一些捐献肾脏的男性在捐献后报告睾丸疼痛;然而,由于之前没有研究包括非捐赠者的对照组,捐赠的原因尚不清楚。目的:比较具有相似基线健康特征的非供体男性与肾切除术后报告睾丸疼痛的男性供体的比例。设计参与者和环境:2004年至2014年,我们在17个移植中心(12个在加拿大,5个在澳大利亚)的肾切除术前招募了1042名活体肾供者(351名男性)。同时招募了396名非捐赠者(126名男性)。随访一直持续到2021年11月。测量:供体和非供体在基线(肾切除术前)和随访时完成相同的测量计划。在随访期间,参与者完成了一份调查问卷,询问他们是否在眼睛、手或睾丸上经历了新的疼痛;那些感到疼痛的人被要求指出疼痛发生在身体的哪一侧(左或右)。351名男性供者中的290名(83%)和126名男性非供者中的97名(77%)在基线后的中位数3年完成疼痛问卷(四分位数间距= 2-6)。方法:使用倾向评分上治疗加权的逆概率来平衡供者和非供者的基线特征。加权后,非供体样本增加到295个伪样本,大多数基线特征在供体和非供体之间相似。结果:基线时,献血者(n = 290)的平均年龄为49岁;83%的人有工作,80%的人已婚;246例(84.8%)行腹腔镜手术,44例(15.2%)行开放手术;253例(87.2%)行左侧肾切除术,37例(12.8%)行右侧肾切除术。在加权分析中,捐精者睾丸疼痛的风险明显高于非捐精者:51/290 (17.6%)vs 7/295 (2.3%);加权风险比为7.8(95%可信区间[CI] = 2.7 ~ 22.8)。捐献人与非捐献人在自我报告的眼痛或手痛方面没有统计学差异。在供体中,睾丸疼痛最常发生在单侧(92.2%)和同一侧(90.2%)。腹腔镜手术与开放手术的供体睾丸疼痛发生率更高:48/246 (19.5%)vs 3/44(6.8%),但左侧肾切除术与右侧肾切除术的供体睾丸疼痛发生率相似:44/253 (17.4%)vs 7/37(18.9%)。局限性:参与者在基线数年后回忆他们的症状,我们没有评估疼痛的时间、严重程度、持续时间或接受过的任何疼痛治疗。结论:肾切除术同侧单侧睾丸疼痛是活体肾捐献的潜在并发症,值得进一步研究。
{"title":"Testicular Pain After Living Kidney Donation: Results From a Multicenter Cohort Study.","authors":"Amit X Garg, Liane S Feldman, Jessica M Sontrop, Meaghan S Cuerden, Jennifer B Arnold, Neil Boudville, Martin Karpinski, Scott Klarenbach, Greg Knoll, Charmaine E Lok, Eric McArthur, Matthew Miller, Mauricio Monroy-Cuadros, Kyla L Naylor, G V Ramesh Prasad, Leroy Storsley, Christopher Nguan","doi":"10.1177/20543581251324610","DOIUrl":"10.1177/20543581251324610","url":null,"abstract":"<p><strong>Background: </strong>Some men who donate a kidney have reported testicular pain after donation; however, attribution to donation is not clear as no prior studies included a comparison group of nondonors.</p><p><strong>Objective: </strong>To examine the proportion of male donors who reported testicular pain in the years after nephrectomy compared to male nondonors with similar baseline health characteristics.</p><p><strong>Design participants and setting: </strong>We enrolled 1042 living kidney donors (351 male) before nephrectomy from 17 transplant centers (12 in Canada and 5 in Australia) from 2004 to 2014. A concurrent sample of 396 nondonors (126 male) was enrolled. Follow-up occurred until November 2021.</p><p><strong>Measurements: </strong>Donors and nondonors completed the same schedule of measurements at baseline (before nephrectomy) and follow-up. During follow-up, participants completed a questionnaire asking whether they had experienced new pain in their eyes, hands, or testicles; those who experienced pain were asked to indicate on which side of the body the pain occurred (left or right). The pain questionnaire was completed by 290 of 351 male donors (83%) and 97 of 126 male nondonors (77%) a median of 3 years after baseline (interquartile range = 2-6).</p><p><strong>Methods: </strong>Inverse probability of treatment weighting on a propensity score was used to balance donors and nondonors on baseline characteristics. After weighting, the nondonor sample increased to a pseudo sample of 295, and most baseline characteristics were similar between donors and nondonors.</p><p><strong>Results: </strong>At baseline, donors (n = 290) were a mean age of 49 years; 83% were employed, and 80% were married; 246 (84.8%) underwent laparoscopic surgery and 44 (15.2%) open surgery; 253 (87.2%) had a left-sided nephrectomy and 37 (12.8%) a right-sided nephrectomy. In the weighted analysis, the risk of testicular pain was significantly greater among donors than nondonors: 51/290 (17.6%) vs 7/295 (2.3%); weighted risk ratio, 7.8 (95% confidence interval [CI] = 2.7 to 22.8). Donors and nondonors did not differ statistically in terms of self-reported eye pain or hand pain. Among donors, the occurrence of testicular pain was most often unilateral (92.2%) and on the same side as the nephrectomy (90.2%). Testicular pain occurred more often in donors who had laparoscopic vs open surgery: 48/246 (19.5%) vs 3/44 (6.8%) but was similar in those who had a left-sided vs right-sided nephrectomy: 44/253 (17.4%) vs 7/37 (18.9%).</p><p><strong>Limitations: </strong>Participants recalled their symptoms several years after baseline, and we did not assess the timing, severity, or duration of pain or any treatments received for the pain.</p><p><strong>Conclusion: </strong>Unilateral testicular pain on the same side of a nephrectomy is a potential complication of living kidney donation that warrants further investigation.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251324610"},"PeriodicalIF":1.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, Canada. 加拿大安大略省2019冠状病毒病大流行后接受维持性透析患者的临床结果和医疗保健利用
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-29 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251328077
Kyla L Naylor, Nivethika Jeyakumar, Yuguang Kang, Stephanie N Dixon, Amit X Garg, Ahmed Al-Jaishi, Peter G Blake, Rahul Chanchlani, Longdi Fu, Ziv Harel, Jane Ip, Ahbijat Kitchlu, Jeffrey C Kwong, Gihad Nesrallah, Matthew J Oliver, Therese A Stukel, Ron Wald, Matthew Weir, Kevin Yau
<p><strong>Background: </strong>The impact of the COVID-19 pandemic on clinical outcomes and healthcare utilization in patients receiving maintenance dialysis is unclear.</p><p><strong>Objective: </strong>To compare the rates of clinical outcomes and healthcare utilization in patients receiving maintenance dialysis (in-center and home modalities) before and during the COVID-19 pandemic.</p><p><strong>Design: </strong>Population-based, repeated cross-sectional study.</p><p><strong>Setting: </strong>Linked administrative healthcare databases from Ontario, Canada.</p><p><strong>Patients: </strong>Adults receiving maintenance dialysis from March 15, 2017, to March 14, 2020 (pre-COVID-19 pandemic period) and from March 15, 2020, to March 14, 2023 (COVID-19 pandemic period).</p><p><strong>Measurements: </strong>Our primary outcome was all-cause mortality. Our secondary outcomes included non-COVID-19-related mortality, all-cause hospitalizations (excluding elective surgeries), emergency room visits, intensive care unit admissions, and hospital admissions with mechanical ventilation. We also examined cardiovascular-related hospitalizations, kidney-related outcomes, and ambulatory visits.</p><p><strong>Methods: </strong>We used Poisson generalized estimating equations to model pre-COVID outcome trends and used these to predict post-COVID outcomes and to estimate the relative change (i.e., the ratio of the observed to the expected rate).</p><p><strong>Results: </strong>In 31 900 individuals receiving maintenance dialysis during the study period, the crude incidence rate (per 1000 person-years) of all-cause mortality was 165.0 in the pre-COVID-19 period, compared to 173.2 during the first year of the pandemic and 171.7 during the first 36 months of the pandemic. After adjustment, there was a statistically significant increase in all-cause mortality in 14 out of the 36 months of the COVID-19 period compared to the pre-COVID-19 period, with 494 recorded COVID-19-related deaths. However, when examining the overall all-cause mortality across the months, the adjusted relative rate (aRR) comparing the observed to expected all-cause mortality rate was not statistically significant in the first year of the pandemic (1.08, 95% CI: 1.00, 1.16) and the first 36 months of the pandemic (1.08, 95% CI: 0.99, 1.18) compared to the pre-pandemic period. The crude incidence rate of non-COVID-19-related mortality was 165.0 in the pre-COVID-19 period, compared to 163.3 during the first year of the pandemic and 157.7 during the first 36 months. After adjustment, there was no substantial change in the rate of non-COVID-19-related deaths in the first year of the pandemic (aRR 1.01, 95% CI: 0.94, 1.09), but there was a substantial decrease in all-cause hospitalization, with an aRR of 0.92 (95% CI: 0.88, 0.97), and a substantial decrease in emergency room visits and intensive care unit admissions; findings were consistent 36 months into the pandemic.</p><p><strong>Limitations: </str
背景:COVID-19大流行对维持性透析患者临床结局和医疗保健利用的影响尚不清楚。目的:比较COVID-19大流行前和期间接受维持性透析(中心和家庭方式)患者的临床结局和医疗保健利用率。设计:基于人群的重复横断面研究。设置:来自加拿大安大略省的链接管理医疗保健数据库。患者:2017年3月15日至2020年3月14日(COVID-19大流行前期)和2020年3月15日至2023年3月14日(COVID-19大流行期)接受维持性透析的成人。测量:我们的主要终点是全因死亡率。我们的次要结局包括与covid -19无关的死亡率、全因住院(不包括选择性手术)、急诊室就诊、重症监护病房住院和机械通气住院。我们还检查了心血管相关住院、肾脏相关结局和门诊就诊。方法:我们使用泊松广义估计方程来模拟covid前的结果趋势,并使用这些方程来预测covid后的结果并估计相对变化(即观察到的比率与预期比率)。结果:在研究期间接受维持性透析的3900例患者中,covid -19前期全因死亡率(每1000人年)的粗发病率为165.0,而大流行第一年为173.2,大流行前36个月为171.7。经调整后,在COVID-19期间的36个月中,有14个月的全因死亡率与COVID-19前相比有统计学显著增加,有494例与COVID-19相关的死亡记录。然而,当检查各个月的总全因死亡率时,与大流行前相比,在大流行的第一年(1.08,95% CI: 1.00, 1.16)和大流行的前36个月(1.08,95% CI: 0.99, 1.18),将观察到的与预期的全因死亡率进行比较的调整相对率(aRR)无统计学意义。在covid -19前期间,非covid -19相关死亡率的粗发病率为165.0,而大流行第一年为163.3,前36个月为157.7。调整后,在大流行的第一年,与covid -19无关的死亡率没有实质性变化(aRR 1.01, 95% CI: 0.94, 1.09),但全因住院率大幅下降,aRR为0.92 (95% CI: 0.88, 0.97),急诊室就诊和重症监护病房入院率大幅下降;调查结果在大流行发生36个月后是一致的。局限性:对其他司法管辖区的外部推广可能有限,因为每个地区的COVID-19发病率不同,实施的缓解战略也不同。结论:在维持透析人群中,在大流行的几个月内,全因死亡率显著升高;然而,在2019冠状病毒病大流行的前36个月,总体全因死亡率并未显著高于预期。尽管急性医疗保健使用率大幅下降,但与covid -19无关的死亡率没有大幅增加。对透析人群的持续监测将有助于进一步了解大流行的长期影响。
{"title":"Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, Canada.","authors":"Kyla L Naylor, Nivethika Jeyakumar, Yuguang Kang, Stephanie N Dixon, Amit X Garg, Ahmed Al-Jaishi, Peter G Blake, Rahul Chanchlani, Longdi Fu, Ziv Harel, Jane Ip, Ahbijat Kitchlu, Jeffrey C Kwong, Gihad Nesrallah, Matthew J Oliver, Therese A Stukel, Ron Wald, Matthew Weir, Kevin Yau","doi":"10.1177/20543581251328077","DOIUrl":"10.1177/20543581251328077","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The impact of the COVID-19 pandemic on clinical outcomes and healthcare utilization in patients receiving maintenance dialysis is unclear.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To compare the rates of clinical outcomes and healthcare utilization in patients receiving maintenance dialysis (in-center and home modalities) before and during the COVID-19 pandemic.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Population-based, repeated cross-sectional study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;Linked administrative healthcare databases from Ontario, Canada.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;Adults receiving maintenance dialysis from March 15, 2017, to March 14, 2020 (pre-COVID-19 pandemic period) and from March 15, 2020, to March 14, 2023 (COVID-19 pandemic period).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Measurements: &lt;/strong&gt;Our primary outcome was all-cause mortality. Our secondary outcomes included non-COVID-19-related mortality, all-cause hospitalizations (excluding elective surgeries), emergency room visits, intensive care unit admissions, and hospital admissions with mechanical ventilation. We also examined cardiovascular-related hospitalizations, kidney-related outcomes, and ambulatory visits.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We used Poisson generalized estimating equations to model pre-COVID outcome trends and used these to predict post-COVID outcomes and to estimate the relative change (i.e., the ratio of the observed to the expected rate).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In 31 900 individuals receiving maintenance dialysis during the study period, the crude incidence rate (per 1000 person-years) of all-cause mortality was 165.0 in the pre-COVID-19 period, compared to 173.2 during the first year of the pandemic and 171.7 during the first 36 months of the pandemic. After adjustment, there was a statistically significant increase in all-cause mortality in 14 out of the 36 months of the COVID-19 period compared to the pre-COVID-19 period, with 494 recorded COVID-19-related deaths. However, when examining the overall all-cause mortality across the months, the adjusted relative rate (aRR) comparing the observed to expected all-cause mortality rate was not statistically significant in the first year of the pandemic (1.08, 95% CI: 1.00, 1.16) and the first 36 months of the pandemic (1.08, 95% CI: 0.99, 1.18) compared to the pre-pandemic period. The crude incidence rate of non-COVID-19-related mortality was 165.0 in the pre-COVID-19 period, compared to 163.3 during the first year of the pandemic and 157.7 during the first 36 months. After adjustment, there was no substantial change in the rate of non-COVID-19-related deaths in the first year of the pandemic (aRR 1.01, 95% CI: 0.94, 1.09), but there was a substantial decrease in all-cause hospitalization, with an aRR of 0.92 (95% CI: 0.88, 0.97), and a substantial decrease in emergency room visits and intensive care unit admissions; findings were consistent 36 months into the pandemic.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/str","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251328077"},"PeriodicalIF":1.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining Referral for a Kidney Transplant Evaluation as a Quality Indicator: A Population-Based Cohort Study. 定义转诊肾移植评估作为质量指标:一项基于人群的队列研究。
IF 1.6 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-21 eCollection Date: 2025-01-01 DOI: 10.1177/20543581251317009
Kyla L Naylor, S Joseph Kim, Bin Luo, Carol Wang, Amit X Garg, Seychelle Yohanna, Darin Treleaven, Susan McKenzie, Jane Ip, Rebecca Cooper, Nadiyah Rehman, Gregory Knoll

Background: Quality indicators are required to identify gaps in care and to improve equitable access to kidney transplants. Referral to a transplant center for an evaluation is the first step toward receiving a kidney transplant, yet widespread reporting on this metric is lacking.

Objective: The objective was to use administrative health care databases to examine multiple ways to define referral for a kidney transplant evaluation by varying clinical inclusion criteria, definitions for end of follow-up, and statistical methodologies.

Design: This is a population-based cohort study.

Setting: This study linked administrative health care databases in Ontario, Canada.

Patients: Adults from Ontario, Canada, with advanced chronic kidney disease (CKD) between April 1, 2017, and March 31, 2018.

Measurements: The primary outcome was the 1-year cumulative incidence of kidney transplant referral.

Methods: We created several patient cohort definitions, varying patient transplant eligibility by health status (eg, whether patients had a recorded contraindication to transplant). We presented results by advanced CKD status (ie, patients approaching the need for dialysis vs receiving maintenance dialysis) and by method of cohort entry (ie, incident only vs prevalent and incident patients combined), resulting in 12 unique cohorts.

Results: Sample size varied substantially from 414 to 4128 depending on the patient cohort definition, with the largest reduction in cohort size occurring when we restricted to a "healthy" (eg, no evidence of cardiovascular disease) group of patients. The 1-year cumulative incidence of transplant referral varied widely across cohorts. For example, in the incident maintenance dialysis population, the cumulative incidence varied more than 2-fold from 16.3% (95% confidence interval [CI] = 15.0%-17.7%) using our most inclusive cohort definition to 40.0% (95% CI = 36.0%-44.5%) using our most restrictive "healthy" cohort of patients.

Limitations: Administrative data may have misclassified individuals' eligibility for kidney transplant.

Conclusions: These results can be used by jurisdictions to measure transplant referral, a necessary step in kidney transplantation that is not equitable for all patients. Adoption of these indicators should drive quality improvement efforts that increase the number of patients referred for transplantation and ensure equitable access for all patient groups.

背景:需要质量指标来确定护理方面的差距,并改善肾脏移植的公平获取。转介到移植中心进行评估是接受肾脏移植的第一步,但缺乏关于这一指标的广泛报道。目的:目的是使用行政卫生保健数据库,通过不同的临床纳入标准、随访结束的定义和统计方法,检查多种方法来定义肾移植评估的转诊。设计:这是一项基于人群的队列研究。背景:本研究连接了加拿大安大略省的行政卫生保健数据库。患者:来自加拿大安大略省,2017年4月1日至2018年3月31日期间患有晚期慢性肾病(CKD)的成年人。测量:主要结果是1年肾脏移植转诊的累积发生率。方法:我们创建了几个患者队列定义,根据健康状况改变患者移植资格(例如,患者是否有移植禁忌症)。我们根据CKD晚期状态(即接近需要透析的患者vs接受维持性透析的患者)和队列输入(即仅发生事件vs普遍发生事件患者和合并发生事件患者)提出了结果,得出了12个独特的队列。结果:根据患者队列定义,样本量在414至4128之间变化很大,当我们限制在“健康”(例如,无心血管疾病证据)患者组时,队列大小减少最大。移植转诊的1年累积发生率在不同队列中差异很大。例如,在事件维持性透析人群中,累积发病率变化超过2倍,从最具包容性的队列定义的16.3%(95%置信区间[CI] = 15.0%-17.7%)到最具限制性的“健康”患者队列的40.0% (95% CI = 36.0%-44.5%)。局限性:管理数据可能对个人的肾移植资格进行了错误的分类。结论:这些结果可用于司法管辖区衡量移植转诊,这是肾移植的必要步骤,但并非对所有患者都公平。采用这些指标应推动质量改进工作,增加转诊移植患者的数量,并确保所有患者群体都能公平获得移植。
{"title":"Defining Referral for a Kidney Transplant Evaluation as a Quality Indicator: A Population-Based Cohort Study.","authors":"Kyla L Naylor, S Joseph Kim, Bin Luo, Carol Wang, Amit X Garg, Seychelle Yohanna, Darin Treleaven, Susan McKenzie, Jane Ip, Rebecca Cooper, Nadiyah Rehman, Gregory Knoll","doi":"10.1177/20543581251317009","DOIUrl":"10.1177/20543581251317009","url":null,"abstract":"<p><strong>Background: </strong>Quality indicators are required to identify gaps in care and to improve equitable access to kidney transplants. Referral to a transplant center for an evaluation is the first step toward receiving a kidney transplant, yet widespread reporting on this metric is lacking.</p><p><strong>Objective: </strong>The objective was to use administrative health care databases to examine multiple ways to define referral for a kidney transplant evaluation by varying clinical inclusion criteria, definitions for end of follow-up, and statistical methodologies.</p><p><strong>Design: </strong>This is a population-based cohort study.</p><p><strong>Setting: </strong>This study linked administrative health care databases in Ontario, Canada.</p><p><strong>Patients: </strong>Adults from Ontario, Canada, with advanced chronic kidney disease (CKD) between April 1, 2017, and March 31, 2018.</p><p><strong>Measurements: </strong>The primary outcome was the 1-year cumulative incidence of kidney transplant referral.</p><p><strong>Methods: </strong>We created several patient cohort definitions, varying patient transplant eligibility by health status (eg, whether patients had a recorded contraindication to transplant). We presented results by advanced CKD status (ie, patients approaching the need for dialysis vs receiving maintenance dialysis) and by method of cohort entry (ie, incident only vs prevalent and incident patients combined), resulting in 12 unique cohorts.</p><p><strong>Results: </strong>Sample size varied substantially from 414 to 4128 depending on the patient cohort definition, with the largest reduction in cohort size occurring when we restricted to a \"healthy\" (eg, no evidence of cardiovascular disease) group of patients. The 1-year cumulative incidence of transplant referral varied widely across cohorts. For example, in the incident maintenance dialysis population, the cumulative incidence varied more than 2-fold from 16.3% (95% confidence interval [CI] = 15.0%-17.7%) using our most inclusive cohort definition to 40.0% (95% CI = 36.0%-44.5%) using our most restrictive \"healthy\" cohort of patients.</p><p><strong>Limitations: </strong>Administrative data may have misclassified individuals' eligibility for kidney transplant.</p><p><strong>Conclusions: </strong>These results can be used by jurisdictions to measure transplant referral, a necessary step in kidney transplantation that is not equitable for all patients. Adoption of these indicators should drive quality improvement efforts that increase the number of patients referred for transplantation and ensure equitable access for all patient groups.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251317009"},"PeriodicalIF":1.6,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11938484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143718102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian Journal of Kidney Health and Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1